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My Year as 1999 ASHG President
Uta Francke
It has been a pleasure and a challenge to serve as ASHG
President during these times of rapid change. Since its
inception in 1948, the Society’s main purpose has been
to serve its members by bringing together investigators
in many areas of human genetics and to encourage and
integrate their efforts by providing a forum for sharing
research findings. This is accomplished primarily
through our annual meeting and our journal, the AJHG.
The ASHG also plays an increasingly important public
role. Numerous current public policy issues and debates
are relevant to human genetics, and the Society is called
upon to offer advice and take a stand. We clearly need
to strengthen our efforts to inform legislators and their
staff, health policy makers, and the general public about
all aspects of human genetics.
Who Are We?
Our Society has over 6,700 members, a 3% increase
from last year. It is truly international, with more than
a thousand members living overseas. Demographic in-
formation, collected over the last two years, reveals great
diversity. About half of the members are engaged pri-
marily in research, 30% in clinical work, 10% in coun-
seling, followed by administration and teaching. This
level of diversity sets our Society apart from other
learned societies. Our meetings and our journal provide
opportunities for learning and interaction across a wide
range of human genetics research and practice. Organ-
izational details can be found at http://www.faseb.org/
genetics/ashg/org.htm.
What Happens at Our Annual Meeting?
The Program Committee, under Lynn Jorde, has fol-
lowed directions by the Board to reorganize the program
of the annual meeting by spreading out the invited
speaker sessions, previously clustered on the first day.
This change serves to balance the broader educational
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perspectives with the reporting of focussed new research
results. Platform presentations of selected abstracts are
considered a valuable component of our meeting and
will be continued. To counteract the trend towards sub-
specialization, however, we enlarged the plenary sessions
in which the best work from different subdisciplines is
presented to the entire group of attendees. Late-breaking
research reports will be integrated in these sessions. To
reach out to the public, Paula Gregory, chair of the In-
formation and Education Committee, organized edu-
cational sessions for high school science teachers, and
Jane Salomon workshops for science writers.
For my Presidential Address, entitled “Human Ge-
netics in the Information Age,” I considered how the
revolution in information technology is changing the
way we do our work—and even the type of work we
will be doing—in research, laboratory diagnostics, as
well as in clinical genetics and counseling. In particular,
I assessed the impact of the information revolution on
three areas that are tightly linked to each other: the
acquisition, dissemination, and interpretation of new
knowledge. The full text is available at the ASHG web-
site: http://www.faseb.org/genetics/ashg/ann-meet/99-
pres/pres-addr-1999.htm. The main points are sum-
marized in the following paragraphs.
To successfully mine the human DNA sequence for
genes that are responsible for or predispose to diseases
and encode potential drug targets, we will need an or-
ganized interdisciplinary effort that includes mathe-
maticians and software engineers to further develop the
informatics tools; biologists to formulate the questions,
to interpret the output, and to annotate the sequence;
and clinicians and pathologists, who understand disease
processes, to suggest possible links between genes and
diseases. Data by themselves are useless, unless they are
turned into knowledge by the interaction of all these
components. Communication between researchers
working with model organisms and human geneticists
will illuminate the connections. Cross-species work-
shops, focusing on specific developmental or signaling
pathways, are planned to facilitate the dialogue.
To disseminate the rapidly growing new knowledge,
we are moving from exclusively paper journals to elec-
tronic versions of the paper journals, with new elec-
tronic-only journals also being launched. The ASHG-
owned journal (AJHG) under the new editor, Stephen
Warren, is shortening the time from submission of ar-
ticles to publication in electronic format. For optimal
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dissemination of new knowledge, however, we also need
free and unlimited access to the electronic literature (i.e.,
to the complete articles, not just the MedLine abstracts
that are currently available through PubMed). Towards
this goal, PubMed Central (PMC), at the National Li-
brary of Medicine on the NIH campus, will be an ar-
chive of primary research papers, in all areas of life
sciences, that offers easy search and retrieval across a
wide range of scientific literature. It is envisioned that
all journals will eventually participate and deposit their
issues after print publication and that new Web-based
journals will be created as part of PMC. The Board of
Directors of ASHG has had intense discussions as to
whether and when the AJHG would be contributed to
PMC. No decision has been reached. The reasons in
favor of this proposal are detailed in my Presidential
Address. Without any doubt, PMC will benefit the com-
munity of scientists by accelerating the discovery of new
knowledge and its worldwide dissemination.
The availability of health-related Web information to
the general public has a significant effect on our practice
of medical genetics and genetic counseling. Although
resources for the genetics professional are growing on
the Web, there is a paucity of online genetic information,
tailored to consumers, which is accurate, up-to-date,
and accessible. Web-based tools for genetic education
for health care professionals and the lay public are
needed. As a professional society, we are concerned
about the discrepancy between the explosion of new
knowledge and the shortage of trained clinical geneti-
cists and counselors who can convey this information
and provide services on a one-on-one basis. The Internet
offers a solution. Web-based genetic information will
increase the awareness of genetic conditions and of the
role of genetic factors in common diseases among the
public. Awareness creates more requests for services.
Interactive Web-based systems will be developed that
can provide accurate, timely, and individualized genetic
information.
What Role Do We Play in the Public and Science
Policy Arena?
Upon our request, the Society has been admitted to full
membership in FASEB (the Federation of American So-
cieties of Experimental Biology), the nation’s largest as-
sociation of biomedical scientists. Made up of 19 soci-
eties, with a combined total of 63,000 members, FASEB
has a strong voice on matters of legislative and public
interest and has campaigned successfully for increased
biomedical research funding. We have appointed ASHG
representatives to the FASEB Board of Directors and to
seven different committees dealing with research fund-
ing, public affairs, and science policy.
In national debates about guidelines and regulations,
many issues have come to the forefront and will con-
tinue to be addressed by the Society, its committees, and
its members. These include the overhaul of the NIH
peer-review system, the establishment of PubMed Cen-
tral, the derivation and use of human pluripotent stem
cells in research, the use of archived human tissues for
research, federal oversight of genetic testing, and pat-
enting of human genes and of genetic diagnostic tests.
The protection of human subjects from research
risks—including the protection of the privacy of genetic
information collected as part of family studies—and is-
sues of informed consent procedures for mentally dis-
abled persons have caught public attention. With the
formation of the Office of Human Research Protection
(OHRP) under the Secretary of HHS—replacing the Of-
fice of Protection from Research Risks (OPRR) under
the NIH Director—there will be increased scrutiny of
informed-consent procedures and of the role of Insti-
tutional Review Boards. These developments are likely
to have considerable impact on researchers in human
genetics.
Under John Carey, an Ad Hoc Committee on Con-
sumer Issues has been formed of researchers and leaders
of advocacy groups. With the support of ASHG, a
workshop was held to address consumer issues sur-
rounding participation in clinical genetic research. The
combined voice of researchers and consumer advocates
will be needed to ensure that the progress of research
will not be impeded by—and will be conducted within
the framework of—existing federal regulations. The
ASHG Social Issues Committee, under Mark Rothstein,
has developed a statement on Genetic Testing in Adop-
tion that will soon be released. As Social Issue Com-
mittees of other genetics organizations (ACMG, NSGC,
and ISONG) are dealing with similar topics, the Board
strongly encouraged joint sessions and activities of the
ASHG committee with these committees.
To improve communication between the ASHG of-
ficers, the membership, and the public, a Communica-
tions Committee has been established by the Board to
redesign our Web site, making it more visible, infor-
mative, and interactive. This effort should enable ASHG
members to be informed of critical issues in a timely
fashion and to act in influencing public policy. Active
participation of the ASHG membership will be essential
for some of these complex issues.
With increasing globalization, the communication
between human genetics societies around the world is
facilitated by the formation of the International Fed-
eration of Human Genetics Societies (IFHGS). The Fed-
eration currently has three full members—the regional
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societies ASHG, ESHG (European Society of Human
Genetics), and HGSA (Human Genetics Society of Aus-
tralasia)—and over 30 national societies as correspond-
ing members. As I am beginning a three-year term as
President of the IFHGS, I look forward to expanding
the activities of this global organization in the infor-
mation age. The new IFHGS web site is http://
www.faseb.org/genetics/ifhgs/index.html. Elaine Strass,
the ASHG Executive Director, deserves recognition for
her expert management of the Society’s office in Be-
thesda and special gratitude for serving as IFHGS Ex-
ecutive Secretary as well.
